Dan Liljenquist

Dan Liljenquist is a Senior Vice President and Chief Strategy Officer for Intermountain Healthcare. He is responsible for helping Intermountain’s Executive Leadership team in setting and achieving its strategic priorities, overseeing Intermountain’s Enterprise Initiative and Market Intelligence & Planning Offices. Prior to joining Intermountain in 2012, Dan served in the Utah State Senate and was nationally recognized for his work on Medicaid and public-sector pension reforms. He is a former strategy consultant with Bain & Company, Inc. Dan is the lead architect and Board Chair of Civica Rx, an initiative to create a not-for-profit generic drug company to “ensure that essential generic medications are available and affordable to everyone”. He is the lead author of Addressing Generic-Drug Market Failures – The Case for Establishing a Nonprofit Manufacturer, published in the New England Journal of Medicine in May 2018. Dan received his Juris Doctorate from The University of Chicago Law School and his Bachelor of Arts in Economics from Brigham Young University. Dan and his wife, Brooke, are the parents of six children and reside in Bountiful, Utah.